- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/64 - Proteinases derived from animal tissue, e.g. rennin
Patent holdings for IPC class C12N 9/64
Total number of patents in this class: 2329
10-year publication summary
183
|
201
|
210
|
208
|
213
|
213
|
170
|
157
|
178
|
96
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1157 |
92 |
Modernatx, Inc. | 1263 |
49 |
Regeneron Pharmaceuticals, Inc. | 4253 |
49 |
Takeda Pharmaceutical Company Limited | 2709 |
42 |
Bioverativ Therapeutics Inc. | 213 |
42 |
Chr. Hansen A/S | 1059 |
36 |
Alexion Pharmaceuticals, Inc. | 637 |
33 |
The Children's Hospital of Philadelphia | 789 |
26 |
The Trustees of the University of Pennsylvania | 4323 |
22 |
Laboratoire Francais du Fractionnement et des Biotechnologies | 294 |
20 |
Vertex Pharmaceuticals Incorporated | 1595 |
19 |
Translate bio, Inc. | 415 |
19 |
F. Hoffmann-La Roche AG | 7921 |
15 |
The Regents of the University of California | 19929 |
15 |
Novozymes A/S | 3320 |
15 |
Omeros Corporation | 307 |
15 |
Opko Biologics Ltd. | 77 |
15 |
Research Development Foundation | 228 |
15 |
Board of Regents, The University of Texas System | 5803 |
14 |
Seikagaku Corporation | 186 |
14 |
Other owners | 1762 |